Mereo Biopharma
Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.
Tuesday, July 23
Tuesday, July 23, 2024
Everything we published on this day.
1 story
Tuesday, July 23
Everything we published on this day.
1 story
Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.